Rebreathing of Carbon Dioxide With a Device Used for Giving Inhalational Anaesthesia
- Conditions
- Anesthetic Ventilatory Requirements
- Interventions
- Device: Anesthetic Conserving Device (AnaConDa )
- Registration Number
- NCT01339013
- Lead Sponsor
- Region Skane
- Brief Summary
The anesthesia gas reflector (AnaConDa) is built on the adsorptive capacity of active carbon which also adsorbs carbon dioxide in exhaled air. Rebreathing of carbon dioxide thus occurs and must be compensated for by increased ventilation. This study aims at determining how much compensation must be given, based on the hypothesis that rebreathing depends on carbon dioxide level in blood and exhaled air.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
- elective coronary artery by-pass graft surgery
- elective valve replacement surgery
- normal left ventricular ejection fraction on preoperative echocardiography
- obstructive lung disease
- restrictive lung disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description AnaConDa Anesthetic Conserving Device (AnaConDa ) -
- Primary Outcome Measures
Name Time Method Airway Dead Space With Devices for Heat and Moisture Exchange of Respiratory Gas. 1 hour A conventional heat and moisture exchanger used in a respiratory circuit during anasthesia was exchanged by an AnaConDa. The AnaConDa causes re-breathing of carbon dioxide which clinically is equivalent to an increased airway dead space. The total airway dead space effect of the AnaConDa, i.e. volume of the device plus rebreathing from the charcoal filter was measured using the Single Breath Test for carbon dioxide, as was airway deadspace of the conventional Heat and Moisture Exchanger. Airway dead space differences between devices was calculated by subtraction of volumes thus achieved. Difference= Airway dead space AnaConDa - Airway dead space conventional Heat and Moisture Exchanger.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital, Cardiothoracic Intensive Care
🇸🇪Lund, Sweden